Dobutamine During Major Abdominal Surgery

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 16, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

April 30, 2026

Conditions
Intraoperative Myocardial Depression
Interventions
DRUG

Dobutamine

In patient assigned to dobutamine administration, dobutamine (concentration: 5 mg mL-1) will be administered with an infusion rate of 3 µg kg-1 min-1 (ideal body weight).

OTHER

Routine care

In patients assigned to routine care, intraoperative hemodynamic management will be in accordance with routine care.

Trial Locations (1)

20246

RECRUITING

University Medical Center Hamburg-Eppendorf, Hamburg

All Listed Sponsors
lead

University of Hamburg-Eppendorf

OTHER

NCT07000994 - Dobutamine During Major Abdominal Surgery | Biotech Hunter | Biotech Hunter